Vaccine Breakthrough Hypoxemic Covid-19 Pneumonia in Patients With Auto-Abs Neutralizing Type I Ifns

Vaccine Breakthrough Hypoxemic Covid-19 Pneumonia in Patients With Auto-Abs Neutralizing Type I Ifns Publisher Pubmed

Bastard P^{1, 2, 3, 4} ; Vazquez SE^{5, 6, 7} ; Liu J^{8, 9} ; Laurie MT⁸ ; Wang CY¹⁰ ; Gervais A^{1, 2} ; Voyer TL^{1, 2} ; Bizien L^{1, 2} ; Zamecnik C¹¹ ; Philippot Q^{1, 2} ; Rosain J^{1, 2} ; Catherinot E¹² ; Willmore A¹⁰ ; Mitchell AM¹⁰ Show All Authors

Bastard P^{1, 2, 3, 4}
Vazquez SE^{5, 6, 7}
Liu J^{8, 9}
Laurie MT⁸
Wang CY¹⁰
Gervais A^{1, 2}
Voyer TL^{1, 2}
Bizien L^{1, 2}
Zamecnik C¹¹
Philippot Q^{1, 2}
Rosain J^{1, 2}
Catherinot E¹²
Willmore A¹⁰
Mitchell AM¹⁰
Bair R¹¹
Garcon P¹³
Kenney H¹⁴
Fekkar A^{1, 2, 15}
Salagianni M¹⁶
Poulakou G¹⁷
Siouti E¹⁶
Sahanic S¹⁸
Tancevski I¹⁸
Weiss G¹⁸
Nagl L¹⁹
Manry J^{1, 2}
Duvlis S^{20, 21}
Arroyosanchez D²²
Artal EP²²
Rubio L⁸
Perani C²³
Bezzi M²⁴
Sottini A²⁵
Quaresima V²⁵
Roussel L^{26, 27}
Vinh DC^{26, 27}
Reyes LF^{28, 29}
Garzaro M³⁰
Hatipoglu N³¹
Boutboul D³²
Tandjaouilambiotte Y^{33, 34, 35}
Borghesi A³⁶
Aliberti A³⁷
Cassaniti I³⁸
Venet F^{39, 40, 41}
Monneret G^{39, 40}
Halwani R^{42, 43}
Sharifaskari NS⁴²
Danielson J¹⁴
Burrel S⁴⁴
Morbieu C⁴⁵
Stepanovskyy Y⁴⁶
Bondarenko A^{46, 111}
Volokha A⁴⁶
Boyarchuk O⁴⁷
Gagro A^{48, 49}
Neuville M⁵⁰
Neven B⁵¹
Keles S⁵²
Hernu R⁵³
Bal A⁵⁴
Novelli A⁵⁵
Novelli G⁵⁶
Saker K^{57, 58}
Ailioaie O⁵⁹
Antoli A⁶⁰
Jeziorski E⁶¹
Rocamorablanch G⁶⁰
Teixeira C⁶²
Delaunay C⁶³
Lhuillier M⁶⁴
Turnier PL⁶³
Zhang Y^{14, 65}
Mahevas M^{66, 67, 68}
Panhammarstrom Q^{69, 143}
Abolhassani H⁶⁹
Bompoil T⁷⁰
Dorgham K⁷¹
Gorochov G^{71, 72}
Laouenan C^{33, 73, 74}
Rodriguezgallego C^{75, 76}
Ng LFP^{77, 78}
Renia L^{77, 78, 79}
Pujol A^{80, 86, 180, 181}
Belot A^{57, 58, 82, 83, 107}
Raffi F⁶³
Allende LM²²
Martinezpicado J^{84, 85, 86, 87}
Ozcelik T⁸⁸
Imberti L²⁵
Notarangelo LD^{14, 170}
Troya J⁸⁹
Solanich X⁶⁰
Zhang SY^{1, 2, 3}
Puel A^{1, 2, 3}
Wilson MR¹¹
Trouilletassant S^{58, 90}
Abel L^{1, 2, 3}
Jouanguy E^{1, 2, 3}
Ye CJ^{10, 91, 92, 93, 94}
Cobat A^{1, 2, 3}
Thompson LM⁹⁵
Andreakos E¹⁶
Zhang Q^{1, 2, 3}
Anderson MS^{7, 96}
Casanova JL^{1, 2, 3, 4, 216, 217}
Derisi JL^{8, 10}
Achille C³⁶
Aiuti A⁹⁸
Almuhsen S⁹⁹
Almulla F¹⁰⁰
Angelini M³⁶
Arias AA^{3, 101, 102}
Aytekin G¹⁰³
Baldanti F^{38, 104}
Banos A¹⁰⁵
Feldman HB¹⁰⁶
Bergami F³⁸
Biggs CM¹⁰⁸
Bogunovic D¹⁰⁹
Bolze A¹¹⁰
Bousfiha AA¹¹²
Brodin P¹¹³
Bryceson Y¹¹⁴
Bustamante CD¹¹⁵
Butte MJ¹¹⁶
Casari G¹¹⁷
Christodoulou J¹¹⁸
Clement B⁵³
Condinoneto A¹¹⁹
Constantinescu SN¹²⁰
Conti F¹²¹
Cooper MA¹²²
Daganou M¹²³
Dalgard CL¹²⁴
Desai M¹²⁵
Drolet BA¹²⁶
El Baghdadi J¹²⁷
Ergun R¹²⁸
Ergun D¹²⁸
Espinosapadilla S¹²⁹
Fellay J^{130, 131}
Flores C^{132, 133, 134, 135}
Franco JL¹³⁶
Froidure A^{137, 138}
Ghirardello S³⁶
Gregersen PK¹³⁹
Grimbacher B¹⁴⁰
Haerynck F¹⁴¹
Hagin D¹⁴²
Hammarstrom L¹⁴³
Heath JR¹⁴⁴
Henrickson SE^{145, 146}
Hsieh EWY¹⁴⁷
Husebye E¹⁴⁸
Imai K¹⁴⁹
Itan Y^{150, 151}
Jarvis ED¹⁵²
Kanat F¹²⁸
Karamitros T¹⁵³
Kisand K¹⁵⁴
Kopcha V¹⁵⁵
Korda M¹⁵⁵
Ku CL¹⁵⁶
Lampropoulou V¹⁶
Lau YL¹⁵⁷
Ling Y¹⁵⁸
Lucas CL¹⁵⁹
Maniatis T¹⁶⁰
Mansouri D¹⁶¹
Marodi L¹⁶²
Meyts I^{163, 164, 165}
Milner JD¹⁶⁶
Mironska K¹⁶⁷
Mogensen TH¹⁶⁸
Mojoli F³⁷
Morandeira F⁶⁰
Morio T¹⁶⁹
Ofarrelly C¹⁷¹
Okada S¹⁷²
Okamoto K¹⁷³
Pagani M³⁷
Papadaki M¹⁶
Pape JW¹⁷⁴
De Diego RP¹⁷⁵
Perlin DS¹⁷⁶
Pesole G¹⁷⁷
Pession A¹²¹
Piralla A³⁸
Pirounaki M¹⁰⁵
Planas AM¹⁷⁸
Prando C¹⁷⁹
Quintanamurci L^{182, 183}
Ramaswamy S¹⁸⁴
Rapti V¹⁷
Resnick I¹⁸⁵
Rigobonnin R⁶⁰
Sanchoshimizu V^{186, 187}
Sediva A¹⁸⁸
Seppanen MRJ^{189, 190}
Shahrooei M^{191, 192}
Shcherbina A¹⁹³
Slaby O¹⁹⁴
Snow AL¹⁹⁵
Solerpalacin P¹⁹⁶
Spaan AN^{3, 197}
Syrigos K¹⁷
Tangye SG^{198, 199}
Tayoun AA¹⁸⁴
Triantafyllia V¹⁶
Tsiodras S²⁰⁰
Tulek B¹²⁸
Turvey SE²⁰¹
Furkan Uddin KM²⁰²
Uddin MJ^{203, 204}
Van De Beek D²⁰⁵
Vatansev H²⁰⁶
Von Bernuth H^{207, 208, 209}
Wauters J²¹⁰
Zatz M²¹¹
Zawadzki P²¹²
Gok F²¹³
Emiroglu M²¹⁴
Alkan G²¹⁵
Yormaz B¹²⁸

Source: Science Immunology Published:2023

Abstract

Life-threatening breakthroughcases of critical COVID-19 are attributed to poor or waning antibody (Ab) response to SARS-CoV-2 vaccines in individuals already at risk. Preexisting auto-Abs neutralizing type I IFNs underlie at least 15% of critical COVID-19 pneumonia cases in unvaccinated individuals; their contribution to hypoxemic breakthrough cases in vaccinated people is unknown. We studied a cohort of 48 individuals (aged 20 to 86 years) who received two doses of a messenger RNA (mRNA) vaccine and developed a breakthrough infection with hypoxemic COVID-19 pneumonia 2 weeks to 4 months later. Ab levels to the vaccine, neutralization of the virus, and auto-Abs to type I IFNs were measured in the plasma. Forty-two individuals had no known deficiency of B cell immunity and a normal Ab response to the vaccine. Among them, 10 (24%) had auto-Abs neutralizing type I IFNs (aged 43 to 86 years). Eight of these 10 patients had auto-Abs neutralizing both IFN-a2 and IFN-w, whereas two neutralized IFN-w only. No patient neutralized IFN-b. Seven neutralized type I IFNs at 10 ng/ml and three at 100 pg/ml only. Seven patients neutralized SARS-CoV-2 D614G and Delta efficiently, whereas one patient neutralized Delta slightly less efficiently. Two of the three patients neutralizing only type I IFNs at 100 pg/ml neutralized both D614G and Delta less efficiently. Despite two mRNA vaccine inoculations and the presence of circulating Abs capable of neutralizing SARS-CoV-2, auto-Abs neutralizing type I IFNs may underlie a notable proportion of hypoxemic COVID-19 pneumonia cases, highlighting the importance of this particularly vulnerable population. Copyright © 2023 The Authors, some rights reserved.

Related Docs

View other Related Docs

1. Higher Covid-19 Pneumonia Risk Associated With Anti-Ifn-Α Than With Anti-Ifn-Ω Auto-Abs in Children, Journal of Experimental Medicine (2024)

2. Human Genetic and Immunological Determinants of Critical Covid-19 Pneumonia, Nature (2022)

3. Role of Autoantibodies Targeting Interferon Type 1 in Covid-19 Severity: A Systematic Review and Meta-Analysis, Journal of Translational Autoimmunity (2023)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (7)

Mohammad Reza Modaresi Estahbanati (2)

Style	Citing Format
MLA	Bastard P, et al.. "Vaccine Breakthrough Hypoxemic Covid-19 Pneumonia in Patients With Auto-Abs Neutralizing Type I Ifns." Science Immunology, vol. 8, no. 90, 2023, pp. -.
APA	Bastard P, Vazquez SE, Liu J, Laurie MT, Wang CY, Gervais A, Voyer TL, Bizien L, Zamecnik C, Philippot Q, Rosain J, Catherinot E, Willmore A, Mitchell AM, Bair R, Garcon P, Kenney H, Fekkar A, Salagianni M, ... Yormaz B (2023). Vaccine Breakthrough Hypoxemic Covid-19 Pneumonia in Patients With Auto-Abs Neutralizing Type I Ifns. Science Immunology, 8(90), -.
Chicago	Bastard P, Vazquez SE, Liu J, Laurie MT, Wang CY, Gervais A, Voyer TL, et al.. "Vaccine Breakthrough Hypoxemic Covid-19 Pneumonia in Patients With Auto-Abs Neutralizing Type I Ifns." Science Immunology 8, no. 90 (2023): -.
Harvard	Bastard P et al. (2023) 'Vaccine Breakthrough Hypoxemic Covid-19 Pneumonia in Patients With Auto-Abs Neutralizing Type I Ifns', Science Immunology, 8(90), pp. -.
Vancouver	Bastard P, Vazquez SE, Liu J, Laurie MT, Wang CY, Gervais A, et al.. Vaccine Breakthrough Hypoxemic Covid-19 Pneumonia in Patients With Auto-Abs Neutralizing Type I Ifns. Science Immunology. 2023;8(90):-.
BibTex	@article{ author = {Bastard P and Vazquez SE and Liu J and Laurie MT and Wang CY and Gervais A and Voyer TL and Bizien L and Zamecnik C and Philippot Q and Rosain J and Catherinot E and Willmore A and Mitchell AM and Bair R and Garcon P and Kenney H and Fekkar A and Salagianni M and Poulakou G and Siouti E and Sahanic S and Tancevski I and Weiss G and Nagl L and Manry J and Duvlis S and Arroyosanchez D and Artal EP and Rubio L and Perani C and Bezzi M and Sottini A and Quaresima V and Roussel L and Vinh DC and Reyes LF and Garzaro M and Hatipoglu N and Boutboul D and Tandjaouilambiotte Y and Borghesi A and Aliberti A and Cassaniti I and Venet F and Monneret G and Halwani R and Sharifaskari NS and Danielson J and Burrel S and Morbieu C and Stepanovskyy Y and Bondarenko A and Volokha A and Boyarchuk O and Gagro A and Neuville M and Neven B and Keles S and Hernu R and Bal A and Novelli A and Novelli G and Saker K and Ailioaie O and Antoli A and Jeziorski E and Rocamorablanch G and Teixeira C and Delaunay C and Lhuillier M and Turnier PL and Zhang Y and Mahevas M and Panhammarstrom Q and Abolhassani H and Bompoil T and Dorgham K and Gorochov G and Laouenan C and Rodriguezgallego C and Ng LFP and Renia L and Pujol A and Belot A and Raffi F and Allende LM and Martinezpicado J and Ozcelik T and Imberti L and Notarangelo LD and Troya J and Solanich X and Zhang SY and Puel A and Wilson MR and Trouilletassant S and Abel L and Jouanguy E and Ye CJ and Cobat A and Thompson LM and Andreakos E and Zhang Q and Anderson MS and Casanova JL and Derisi JL and Achille C and Aiuti A and Almuhsen S and Almulla F and Angelini M and Arias AA and Aytekin G and Baldanti F and Banos A and Feldman HB and Bergami F and Biggs CM and Bogunovic D and Bolze A and Bousfiha AA and Brodin P and Bryceson Y and Bustamante CD and Butte MJ and Casari G and Christodoulou J and Clement B and Condinoneto A and Constantinescu SN and Conti F and Cooper MA and Daganou M and Dalgard CL and Desai M and Drolet BA and El Baghdadi J and Ergun R and Ergun D and Espinosapadilla S and Fellay J and Flores C and Franco JL and Froidure A and Ghirardello S and Gregersen PK and Grimbacher B and Haerynck F and Hagin D and Hammarstrom L and Heath JR and Henrickson SE and Hsieh EWY and Husebye E and Imai K and Itan Y and Jarvis ED and Kanat F and Karamitros T and Kisand K and Kopcha V and Korda M and Ku CL and Lampropoulou V and Lau YL and Ling Y and Lucas CL and Maniatis T and Mansouri D and Marodi L and Meyts I and Milner JD and Mironska K and Mogensen TH and Mojoli F and Morandeira F and Morio T and Ofarrelly C and Okada S and Okamoto K and Pagani M and Papadaki M and Pape JW and De Diego RP and Perlin DS and Pesole G and Pession A and Piralla A and Pirounaki M and Planas AM and Prando C and Quintanamurci L and Ramaswamy S and Rapti V and Resnick I and Rigobonnin R and Sanchoshimizu V and Sediva A and Seppanen MRJ and Shahrooei M and Shcherbina A and Slaby O and Snow AL and Solerpalacin P and Spaan AN and Syrigos K and Tangye SG and Tayoun AA and Triantafyllia V and Tsiodras S and Tulek B and Turvey SE and Furkan Uddin KM and Uddin MJ and Van De Beek D and Vatansev H and Von Bernuth H and Wauters J and Zatz M and Zawadzki P and Gok F and Emiroglu M and Alkan G and Yormaz B}, title = {Vaccine Breakthrough Hypoxemic Covid-19 Pneumonia in Patients With Auto-Abs Neutralizing Type I Ifns}, journal = {Science Immunology}, volume = {8}, number = {90}, pages = {-}, year = {2023} }
RIS	TY - JOUR AU - Bastard P AU - Vazquez SE AU - Liu J AU - Laurie MT AU - Wang CY AU - Gervais A AU - Voyer TL AU - Bizien L AU - Zamecnik C AU - Philippot Q AU - Rosain J AU - Catherinot E AU - Willmore A AU - Mitchell AM AU - Bair R AU - Garcon P AU - Kenney H AU - Fekkar A AU - Salagianni M AU - Poulakou G AU - Siouti E AU - Sahanic S AU - Tancevski I AU - Weiss G AU - Nagl L AU - Manry J AU - Duvlis S AU - Arroyosanchez D AU - Artal EP AU - Rubio L AU - Perani C AU - Bezzi M AU - Sottini A AU - Quaresima V AU - Roussel L AU - Vinh DC AU - Reyes LF AU - Garzaro M AU - Hatipoglu N AU - Boutboul D AU - Tandjaouilambiotte Y AU - Borghesi A AU - Aliberti A AU - Cassaniti I AU - Venet F AU - Monneret G AU - Halwani R AU - Sharifaskari NS AU - Danielson J AU - Burrel S AU - Morbieu C AU - Stepanovskyy Y AU - Bondarenko A AU - Volokha A AU - Boyarchuk O AU - Gagro A AU - Neuville M AU - Neven B AU - Keles S AU - Hernu R AU - Bal A AU - Novelli A AU - Novelli G AU - Saker K AU - Ailioaie O AU - Antoli A AU - Jeziorski E AU - Rocamorablanch G AU - Teixeira C AU - Delaunay C AU - Lhuillier M AU - Turnier PL AU - Zhang Y AU - Mahevas M AU - Panhammarstrom Q AU - Abolhassani H AU - Bompoil T AU - Dorgham K AU - Gorochov G AU - Laouenan C AU - Rodriguezgallego C AU - Ng LFP AU - Renia L AU - Pujol A AU - Belot A AU - Raffi F AU - Allende LM AU - Martinezpicado J AU - Ozcelik T AU - Imberti L AU - Notarangelo LD AU - Troya J AU - Solanich X AU - Zhang SY AU - Puel A AU - Wilson MR AU - Trouilletassant S AU - Abel L AU - Jouanguy E AU - Ye CJ AU - Cobat A AU - Thompson LM AU - Andreakos E AU - Zhang Q AU - Anderson MS AU - Casanova JL AU - Derisi JL AU - Achille C AU - Aiuti A AU - Almuhsen S AU - Almulla F AU - Angelini M AU - Arias AA AU - Aytekin G AU - Baldanti F AU - Banos A AU - Feldman HB AU - Bergami F AU - Biggs CM AU - Bogunovic D AU - Bolze A AU - Bousfiha AA AU - Brodin P AU - Bryceson Y AU - Bustamante CD AU - Butte MJ AU - Casari G AU - Christodoulou J AU - Clement B AU - Condinoneto A AU - Constantinescu SN AU - Conti F AU - Cooper MA AU - Daganou M AU - Dalgard CL AU - Desai M AU - Drolet BA AU - El Baghdadi J AU - Ergun R AU - Ergun D AU - Espinosapadilla S AU - Fellay J AU - Flores C AU - Franco JL AU - Froidure A AU - Ghirardello S AU - Gregersen PK AU - Grimbacher B AU - Haerynck F AU - Hagin D AU - Hammarstrom L AU - Heath JR AU - Henrickson SE AU - Hsieh EWY AU - Husebye E AU - Imai K AU - Itan Y AU - Jarvis ED AU - Kanat F AU - Karamitros T AU - Kisand K AU - Kopcha V AU - Korda M AU - Ku CL AU - Lampropoulou V AU - Lau YL AU - Ling Y AU - Lucas CL AU - Maniatis T AU - Mansouri D AU - Marodi L AU - Meyts I AU - Milner JD AU - Mironska K AU - Mogensen TH AU - Mojoli F AU - Morandeira F AU - Morio T AU - Ofarrelly C AU - Okada S AU - Okamoto K AU - Pagani M AU - Papadaki M AU - Pape JW AU - De Diego RP AU - Perlin DS AU - Pesole G AU - Pession A AU - Piralla A AU - Pirounaki M AU - Planas AM AU - Prando C AU - Quintanamurci L AU - Ramaswamy S AU - Rapti V AU - Resnick I AU - Rigobonnin R AU - Sanchoshimizu V AU - Sediva A AU - Seppanen MRJ AU - Shahrooei M AU - Shcherbina A AU - Slaby O AU - Snow AL AU - Solerpalacin P AU - Spaan AN AU - Syrigos K AU - Tangye SG AU - Tayoun AA AU - Triantafyllia V AU - Tsiodras S AU - Tulek B AU - Turvey SE AU - Furkan Uddin KM AU - Uddin MJ AU - Van De Beek D AU - Vatansev H AU - Von Bernuth H AU - Wauters J AU - Zatz M AU - Zawadzki P AU - Gok F AU - Emiroglu M AU - Alkan G AU - Yormaz B TI - Vaccine Breakthrough Hypoxemic Covid-19 Pneumonia in Patients With Auto-Abs Neutralizing Type I Ifns JO - Science Immunology VL - 8 IS - 90 SP - EP - PY - 2023 ER -

Style

Citing Format

MLA

Bastard P, et al.. "Vaccine Breakthrough Hypoxemic Covid-19 Pneumonia in Patients With Auto-Abs Neutralizing Type I Ifns." Science Immunology, vol. 8, no. 90, 2023, pp. -.

APA

Bastard P, Vazquez SE, Liu J, Laurie MT, Wang CY, Gervais A, Voyer TL, Bizien L, Zamecnik C, Philippot Q, Rosain J, Catherinot E, Willmore A, Mitchell AM, Bair R, Garcon P, Kenney H, Fekkar A, Salagianni M, ... Yormaz B (2023). Vaccine Breakthrough Hypoxemic Covid-19 Pneumonia in Patients With Auto-Abs Neutralizing Type I Ifns. Science Immunology, 8(90), -.

Chicago

Bastard P, Vazquez SE, Liu J, Laurie MT, Wang CY, Gervais A, Voyer TL, et al.. "Vaccine Breakthrough Hypoxemic Covid-19 Pneumonia in Patients With Auto-Abs Neutralizing Type I Ifns." Science Immunology 8, no. 90 (2023): -.

Harvard

Bastard P et al. (2023) 'Vaccine Breakthrough Hypoxemic Covid-19 Pneumonia in Patients With Auto-Abs Neutralizing Type I Ifns', Science Immunology, 8(90), pp. -.

Vancouver

Bastard P, Vazquez SE, Liu J, Laurie MT, Wang CY, Gervais A, et al.. Vaccine Breakthrough Hypoxemic Covid-19 Pneumonia in Patients With Auto-Abs Neutralizing Type I Ifns. Science Immunology. 2023;8(90):-.

BibTex

@article{ author = {Bastard P and Vazquez SE and Liu J and Laurie MT and Wang CY and Gervais A and Voyer TL and Bizien L and Zamecnik C and Philippot Q and Rosain J and Catherinot E and Willmore A and Mitchell AM and Bair R and Garcon P and Kenney H and Fekkar A and Salagianni M and Poulakou G and Siouti E and Sahanic S and Tancevski I and Weiss G and Nagl L and Manry J and Duvlis S and Arroyosanchez D and Artal EP and Rubio L and Perani C and Bezzi M and Sottini A and Quaresima V and Roussel L and Vinh DC and Reyes LF and Garzaro M and Hatipoglu N and Boutboul D and Tandjaouilambiotte Y and Borghesi A and Aliberti A and Cassaniti I and Venet F and Monneret G and Halwani R and Sharifaskari NS and Danielson J and Burrel S and Morbieu C and Stepanovskyy Y and Bondarenko A and Volokha A and Boyarchuk O and Gagro A and Neuville M and Neven B and Keles S and Hernu R and Bal A and Novelli A and Novelli G and Saker K and Ailioaie O and Antoli A and Jeziorski E and Rocamorablanch G and Teixeira C and Delaunay C and Lhuillier M and Turnier PL and Zhang Y and Mahevas M and Panhammarstrom Q and Abolhassani H and Bompoil T and Dorgham K and Gorochov G and Laouenan C and Rodriguezgallego C and Ng LFP and Renia L and Pujol A and Belot A and Raffi F and Allende LM and Martinezpicado J and Ozcelik T and Imberti L and Notarangelo LD and Troya J and Solanich X and Zhang SY and Puel A and Wilson MR and Trouilletassant S and Abel L and Jouanguy E and Ye CJ and Cobat A and Thompson LM and Andreakos E and Zhang Q and Anderson MS and Casanova JL and Derisi JL and Achille C and Aiuti A and Almuhsen S and Almulla F and Angelini M and Arias AA and Aytekin G and Baldanti F and Banos A and Feldman HB and Bergami F and Biggs CM and Bogunovic D and Bolze A and Bousfiha AA and Brodin P and Bryceson Y and Bustamante CD and Butte MJ and Casari G and Christodoulou J and Clement B and Condinoneto A and Constantinescu SN and Conti F and Cooper MA and Daganou M and Dalgard CL and Desai M and Drolet BA and El Baghdadi J and Ergun R and Ergun D and Espinosapadilla S and Fellay J and Flores C and Franco JL and Froidure A and Ghirardello S and Gregersen PK and Grimbacher B and Haerynck F and Hagin D and Hammarstrom L and Heath JR and Henrickson SE and Hsieh EWY and Husebye E and Imai K and Itan Y and Jarvis ED and Kanat F and Karamitros T and Kisand K and Kopcha V and Korda M and Ku CL and Lampropoulou V and Lau YL and Ling Y and Lucas CL and Maniatis T and Mansouri D and Marodi L and Meyts I and Milner JD and Mironska K and Mogensen TH and Mojoli F and Morandeira F and Morio T and Ofarrelly C and Okada S and Okamoto K and Pagani M and Papadaki M and Pape JW and De Diego RP and Perlin DS and Pesole G and Pession A and Piralla A and Pirounaki M and Planas AM and Prando C and Quintanamurci L and Ramaswamy S and Rapti V and Resnick I and Rigobonnin R and Sanchoshimizu V and Sediva A and Seppanen MRJ and Shahrooei M and Shcherbina A and Slaby O and Snow AL and Solerpalacin P and Spaan AN and Syrigos K and Tangye SG and Tayoun AA and Triantafyllia V and Tsiodras S and Tulek B and Turvey SE and Furkan Uddin KM and Uddin MJ and Van De Beek D and Vatansev H and Von Bernuth H and Wauters J and Zatz M and Zawadzki P and Gok F and Emiroglu M and Alkan G and Yormaz B}, title = {Vaccine Breakthrough Hypoxemic Covid-19 Pneumonia in Patients With Auto-Abs Neutralizing Type I Ifns}, journal = {Science Immunology}, volume = {8}, number = {90}, pages = {-}, year = {2023} }

RIS

TY - JOUR
AU - Bastard P
AU - Vazquez SE
AU - Liu J
AU - Laurie MT
AU - Wang CY
AU - Gervais A
AU - Voyer TL
AU - Bizien L
AU - Zamecnik C
AU - Philippot Q
AU - Rosain J
AU - Catherinot E
AU - Willmore A
AU - Mitchell AM
AU - Bair R
AU - Garcon P
AU - Kenney H
AU - Fekkar A
AU - Salagianni M
AU - Poulakou G
AU - Siouti E
AU - Sahanic S
AU - Tancevski I
AU - Weiss G
AU - Nagl L
AU - Manry J
AU - Duvlis S
AU - Arroyosanchez D
AU - Artal EP
AU - Rubio L
AU - Perani C
AU - Bezzi M
AU - Sottini A
AU - Quaresima V
AU - Roussel L
AU - Vinh DC
AU - Reyes LF
AU - Garzaro M
AU - Hatipoglu N
AU - Boutboul D
AU - Tandjaouilambiotte Y
AU - Borghesi A
AU - Aliberti A
AU - Cassaniti I
AU - Venet F
AU - Monneret G
AU - Halwani R
AU - Sharifaskari NS
AU - Danielson J
AU - Burrel S
AU - Morbieu C
AU - Stepanovskyy Y
AU - Bondarenko A
AU - Volokha A
AU - Boyarchuk O
AU - Gagro A
AU - Neuville M
AU - Neven B
AU - Keles S
AU - Hernu R
AU - Bal A
AU - Novelli A
AU - Novelli G
AU - Saker K
AU - Ailioaie O
AU - Antoli A
AU - Jeziorski E
AU - Rocamorablanch G
AU - Teixeira C
AU - Delaunay C
AU - Lhuillier M
AU - Turnier PL
AU - Zhang Y
AU - Mahevas M
AU - Panhammarstrom Q
AU - Abolhassani H
AU - Bompoil T
AU - Dorgham K
AU - Gorochov G
AU - Laouenan C
AU - Rodriguezgallego C
AU - Ng LFP
AU - Renia L
AU - Pujol A
AU - Belot A
AU - Raffi F
AU - Allende LM
AU - Martinezpicado J
AU - Ozcelik T
AU - Imberti L
AU - Notarangelo LD
AU - Troya J
AU - Solanich X
AU - Zhang SY
AU - Puel A
AU - Wilson MR
AU - Trouilletassant S
AU - Abel L
AU - Jouanguy E
AU - Ye CJ
AU - Cobat A
AU - Thompson LM
AU - Andreakos E
AU - Zhang Q
AU - Anderson MS
AU - Casanova JL
AU - Derisi JL
AU - Achille C
AU - Aiuti A
AU - Almuhsen S
AU - Almulla F
AU - Angelini M
AU - Arias AA
AU - Aytekin G
AU - Baldanti F
AU - Banos A
AU - Feldman HB
AU - Bergami F
AU - Biggs CM
AU - Bogunovic D
AU - Bolze A
AU - Bousfiha AA
AU - Brodin P
AU - Bryceson Y
AU - Bustamante CD
AU - Butte MJ
AU - Casari G
AU - Christodoulou J
AU - Clement B
AU - Condinoneto A
AU - Constantinescu SN
AU - Conti F
AU - Cooper MA
AU - Daganou M
AU - Dalgard CL
AU - Desai M
AU - Drolet BA
AU - El Baghdadi J
AU - Ergun R
AU - Ergun D
AU - Espinosapadilla S
AU - Fellay J
AU - Flores C
AU - Franco JL
AU - Froidure A
AU - Ghirardello S
AU - Gregersen PK
AU - Grimbacher B
AU - Haerynck F
AU - Hagin D
AU - Hammarstrom L
AU - Heath JR
AU - Henrickson SE
AU - Hsieh EWY
AU - Husebye E
AU - Imai K
AU - Itan Y
AU - Jarvis ED
AU - Kanat F
AU - Karamitros T
AU - Kisand K
AU - Kopcha V
AU - Korda M
AU - Ku CL
AU - Lampropoulou V
AU - Lau YL
AU - Ling Y
AU - Lucas CL
AU - Maniatis T
AU - Mansouri D
AU - Marodi L
AU - Meyts I
AU - Milner JD
AU - Mironska K
AU - Mogensen TH
AU - Mojoli F
AU - Morandeira F
AU - Morio T
AU - Ofarrelly C
AU - Okada S
AU - Okamoto K
AU - Pagani M
AU - Papadaki M
AU - Pape JW
AU - De Diego RP
AU - Perlin DS
AU - Pesole G
AU - Pession A
AU - Piralla A
AU - Pirounaki M
AU - Planas AM
AU - Prando C
AU - Quintanamurci L
AU - Ramaswamy S
AU - Rapti V
AU - Resnick I
AU - Rigobonnin R
AU - Sanchoshimizu V
AU - Sediva A
AU - Seppanen MRJ
AU - Shahrooei M
AU - Shcherbina A
AU - Slaby O
AU - Snow AL
AU - Solerpalacin P
AU - Spaan AN
AU - Syrigos K
AU - Tangye SG
AU - Tayoun AA
AU - Triantafyllia V
AU - Tsiodras S
AU - Tulek B
AU - Turvey SE
AU - Furkan Uddin KM
AU - Uddin MJ
AU - Van De Beek D
AU - Vatansev H
AU - Von Bernuth H
AU - Wauters J
AU - Zatz M
AU - Zawadzki P
AU - Gok F
AU - Emiroglu M
AU - Alkan G
AU - Yormaz B
TI - Vaccine Breakthrough Hypoxemic Covid-19 Pneumonia in Patients With Auto-Abs Neutralizing Type I Ifns
JO - Science Immunology
VL - 8
IS - 90
SP -
EP -
PY - 2023
ER -

Science Communicator Platform

Authors

Abstract